CombiMatrix hunts for new CEO in restructuring

CombiMatrix is planning a change in the CEO's office as it restructures. The biotech company says that CEO Amit Kumar will step down after the company finds a new CEO to fill his shoes. And the company plans to increase its focus on diagnostic services, cutting its burn rate up to 60 percent. Story

Suggested Articles

Last month, rumors out of Bloomberg whispered that Gilead, more known for its COVID-19 work these days, was gearing up for a major stake in Arcus.

The NGOs think Big Pharma controls the agenda of the IMI, leading it to prioritize areas that are profitable for drugmakers over public health needs.

Scientists at McMaster University and the University of Toronto have formed Empirica Therapeutics to bring a CAR-T for glioblastoma into the clinic.